Healthcare - Biotechnology - NASDAQ - US
$ 1.245
-17 %
$ 78.9 M
Market Cap
-1.28
P/E
CASH FLOW STATEMENT
-40 M
OPERATING CASH FLOW
25 M
INVESTING CASH FLOW
11.9 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Cue Biopharma, Inc.
| Net Income | -50.7 M |
| Depreciation & Amortization | 3.44 M |
| Capital Expenditures | 0 |
| Stock-Based Compensation | 8.18 M |
| Change in Working Capital | -934 K |
| Others | 27 K |
| Free Cash Flow | -40 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | |
|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||||||
| Net Income | (50.7) | (53.0) | (44.2) | (44.8) | (36.7) | (39.0) | (23.2) | (7.7) | (1.9) |
| Depreciation & Amortization | 3.4 | 1.8 | (1.8) | 1.1 | 5.2 | 0.8 | 0.4 | 0.2 | 44.8 K |
| Deferred Income Tax | 0 | 0 | 0 | 83.7 K | 18.2 K | 79.9 K | 10.7 K | 0 | 0 |
| Stock Based Compensation | 8.2 | 9.5 | 11.5 | 10.5 | 6.5 | 7.2 | 2.8 | 0.9 | 0 |
| Other Operating Activities | 90 K | (0.5) | 26.1 K | (0.6) | (4.3) | 0.3 | 4.9 | 65.9 K | 79.5 K |
| Change in Working Capital | (0.9) | 0.4 | (4.4) | 1.2 | (1.5) | 4.2 | 2.9 | 0.5 | 0.1 |
| Cash From Operations | (40.0) | (41.8) | (38.8) | (32.5) | (30.8) | (26.4) | (12.2) | (6.0) | (1.7) |
| INVESTING CASH FLOW | |||||||||
| Capital Expenditures | 0 | (0.2) | (0.9) | (0.6) | 46.4 K | (1.9) | (1.2) | (0.5) | (0.8) |
| Other Items | 25.0 | (24.4) | 10.0 | 5.1 | 3.5 | (18.5) | 35 | 33 | 50 K |
| Cash From Investing Activities | 25.0 | (24.6) | 9.1 | 4.5 | 3.4 | (20.4) | (1.2) | (0.5) | (0.8) |
| FINANCING CASH FLOW | |||||||||
| Common Stock Repurchased | 0 | 0 | 0 | (0.3) | 91 K | 0 | (4.2) | (1.4) | (1.1) |
| Total Debt Repaid | (2.0) | 10.0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0.5 | 4.4 | 1.8 | 1.9 | 1.8 | 12.5 K | 9.01 K | 0 | 1 K |
| Cash From Financing Activities | 11.9 | 53.7 | 19.2 | 58.6 | 50.8 | 4.2 | 62.0 | 15.0 | 8.9 |
| CHANGE IN CASH | |||||||||
| Net Change In Cash | (3.1) | (12.8) | (10.5) | 30.6 | 23.4 | (42.6) | 48.6 | 8.5 | 6.4 |
| FREE CASH FLOW | |||||||||
| Free Cash Flow | (40.0) | (42.0) | (39.8) | (33.1) | (30.8) | (28.3) | (13.4) | (6.5) | (2.4) |